Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



GEN News Highlights

Back to Item »

Patents Regarding Cancer and MS Added to Bioniche’s and BioMS’ Portfolio, Respectively

Bioniche received three patents related to its technology for treatment and prediction, and BioMS’ was regarding prediction of MS therapy efficacy.

Forward this item to a colleague:
Your name
Your email
(Separate multiple addresses by commas)
 
Colleague's email
(Separate multiple addresses by commas)
 
Personal Message
(optional)
 
 
 

GEN Poll

More » Poll Results » Archive »

The Price of BRCA Testing

Is getting a genetic test worth the multi-thousand dollar price?

Suggest a Poll